NGL Fine-Chem Surges on 43% Revenue Growth & Stellar Profit Jump

CHEMICALS
Whalesbook Logo
AuthorAnanya Iyer|Published at:
NGL Fine-Chem Surges on 43% Revenue Growth & Stellar Profit Jump
Overview

NGL Fine-Chem reported a stellar Q3 FY26, with revenue up 43.11% YoY to ₹127.51 crore and Profit After Tax (PAT) surging 1129.12% to ₹15.69 crore. This performance was driven by higher volumes and operational efficiencies, boosting EBITDA margins by 1178 basis points to 17.50%. The company is progressing with a ₹210 crore expansion project, targeting commissioning in Q1FY27 and commercial production from H2 FY27, aiming for an asset turnover exceeding two times. Significant strides in regulatory filings for controlled markets were also noted.

📉 The Financial Deep Dive

NGL Fine-Chem Limited has posted an exceptionally strong third quarter for FY26, demonstrating robust top-line expansion and significant margin improvement.

The Numbers:

  • Revenue: Revenue from operations surged by 43.11% year-on-year to ₹127.51 crore in Q3 FY26, driven by increased volumes. For the nine months ended December 31, 2025 (9M FY26), revenue grew by 28.74% YoY to ₹351.89 crore.
  • Profitability: EBITDA witnessed a remarkable 337.81% year-on-year jump to ₹22.31 crore in Q3 FY26. The EBITDA margin expanded by 1178 basis points to 17.50%, a testament to operational efficiencies and stable pricing. Profit After Tax (PAT) skyrocketed by 1129.12% YoY to ₹15.69 crore in the quarter. For 9M FY26, PAT grew 70.16% YoY to ₹34.56 crore.
  • Other Income: The company also reported a considerable year-on-year increase in 'Other Income' during Q3 FY26.

Financial Deep Dive:

  • Income Statement: The substantial growth in EBITDA and PAT, coupled with margin expansion, highlights improved operational leverage and cost management. The increase in 'Other Income' provided an additional boost to the bottom line for the quarter.
  • Balance Sheet: As of H1FY26, Total Equity and Liabilities rose to ₹484.12 crore from ₹433.39 crore in FY25. The Net Block (fixed assets) increased to ₹169.73 crore from ₹142.12 crore, indicating continued investment in productive assets. Total borrowings saw an increase, reaching ₹88.21 crore in H1FY26 compared to ₹73.16 crore in FY25.
  • Cash Flow: Cash flow from operating activities stood at ₹16.77 crore for H1FY26, a decrease from ₹35.82 crore in FY25. Investing activities saw an outflow of ₹14.37 crore for capital expenditure in H1FY26, a reduction from ₹34.55 crore in FY25. The company maintained positive net cash flow.

🚩 Risks & Outlook

Management commentary points to firm demand across geographies and customer segments. The key growth driver is the ongoing Phase II expansion program, which is on track for commissioning in Q1FY27 and commercial production from H2 FY27. The project investment has been revised to approximately ₹210 crore, with funding mix of debt (capped at ₹85 crore) and internal accruals. This expansion is strategically aimed at achieving an asset turnover of over two times in the long term. Significant progress in regulatory filings for controlled markets, including several CEPs, ASMF, and US VMF submissions, is expected to unlock new growth avenues.

However, a notable point is the decrease in operating cash flow from ₹35.82 crore in FY25 to ₹16.77 crore in H1FY26, which investors should monitor alongside the increasing debt levels as the company funds its expansion. The successful execution of the expansion project and timely regulatory approvals will be critical for sustaining this growth trajectory.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.